Over the course of the last decade, the use of drones has been trialled for use in expanding the ability of supply chain professionals to deliver temperature-sensitive drug therapies and life-saving vaccines.
Drones are transforming the pharmaceutical supply chain transportation model at a swift tempo, enabling the safe delivery of life-saving vaccines and medical supplies to areas impacted by natural disaster or an epidemic outbreak in record time, where poor infrastructure and instability can limit patient access. The impact of this new technology on the supply chain industry, including the biopharmaceutical cold chain, is monumental.
However, the innovation and implementation of drone technology are outpacing international aviation regulatory bodies ability to enact current oversight. NASA has taken the first step in attempting to develop a protocol, but determining and enforcing the rules is in the jurisdiction of the FAA. The FAA released recent drone-related regulations in 2016 (Small UAS Rule – Part 107). Unfortunately, Part 107 does not address regulations specific to drone delivery, nor does it define rules for pilotless flight. The regulations include operational limitations for drones, including specifying maximum weight (25kg), flight altitude (400ft), and a stipulation that they may be operated only during daylight hours. The constraint raising the largest barricade to unleash the potential of drones is the requirement to maintain the visual line of sight (VLOS), preventing UAVs from performing long-distance tasks outside the sight of an observer.
Drones in the Cold Chain – a Game Changer
Adopting drone delivery technology will open new markets and service areas previously considered not cost effective or too risky, such as engagement in humanitarian logistics, emergency, and disaster response. Drone delivery can speed up laboratory test results, blood supply, and organ transplant shipping and service to rural areas around the world previously thought unmanageable. Integrating drone technology fortifies your existing supply chain and widens your access to a larger patient population. Using drones to deliver drug products causes a paradigm shift from operating within a predictive model to operating within a responsive model of drug delivery logistics, especially for the last mile delivery to the patient.
General benefits of drone delivery include:
- Drones are fast – drug product can travel from warehouse or pharmacy to patient in 30 minutes. Some drones travel at a speed of 100km per hour at low altitude.
- Drones are efficient – Experts believe that drones have the potential to reduce costs within the last mile and increase efficiency simultaneously.
- Drones are sustainable – Battery operated machinery minimises environmental impact.
- Drones are humanitarian – They are ideal for delivering medicine and healthcare supplies to remote, underdeveloped, or dangerous locations due to war and/or epidemic outbreak.
- Drones are urban – Drones are ideal for delivering to areas that are overpopulated, traffic-ridden, and too time-consuming to reach, such as large cities with dense population.
- Drones are innovative – Adding drones to your supply chain sets you apart as an innovator among your peers, many of whom (age 30-49 demographic) believe the pharmaceutical/medical market will benefit most from drone delivery.
Successful Drone Delivery in the Real World
The future of drone deliveries may lie in the hands of regulators. Less crowded air space and fewer regulations are ideal for successful drone delivery implementations. Zipline’s success story in a less developed country with challenging geography is a good example. California – based Zipline has built the swiftest and reliable delivery drone, capable of reaching speeds of up to 100km per hour, for the biopharmaceutical supply chain for humanitarian outreach. Motivated by suboptimal logistics infrastructure and rudimentary, vulnerable, and expensive drug product storage facilities in Rwanda, Zipline recognized an opportunity to improve the delivery of life-saving blood. They responded to the challenge by organizing a project with UPS and GAVI to collaboratively establish and test a drone delivery program.
The project team fabricated launch and landing stations capable of transporting up to 150 emergency deliveries per day to 21 transfusing stations in the western region of the country. Upon receipt of an order for blood, the orders were immediately packaged and sent to the patient. With flying at over 100km per hour, the life-saving blood and medical supplies are delivered within thirty minutes to the patient from the sky via parachute, which was once a 5-hour round-trip truck drive. Zipline accredits the speed of their drones to their ability to maintain a proper cold chain network.
Early public acceptance of drone delivery networks in urban areas will revolve around hospitals. And once drones can safely and reliably carry blood and medical supplies, that will pave the way to other kinds of drone deliveries. Last October Swiss Post launched a medical transport network in Lugano, Switzerland, using drones made by another Bay Area company, Matternet. So far, the drones have made 350 deliveries, about 5 to 15 per day.
In the US, Matternet is partnering with the city of Palo Alto on a proposal to shuttle blood to Stanford hospitals. Flirtey, a drone manufacturer in Reno, NV is focusing on using its aircraft for last-mile delivery of defibrillators, devices the company thinks could save hundreds of thousands of lives in America each year, by increasing the chance of survival from out-of-hospital cardiac arrest. Beyond the blood and medical supply deliveries, drones could transform another key component of healthcare, lab tests. Timely test results help doctors diagnose infections and reduce guesswork in prescribing medications. Some of those decisions have life-or-death implications.
Globally, last summer, UNICEF worked with local governments in the African country of Malawi to launch a drone corridor for companies, universities, and nonprofits to fly test missions there. UNICEF also invited groups to transport vaccines in Vanuatu, the South Pacific nation made up of roughly 80 islands east of Australia. The drone corridors run on a barter system, says Chris Fabian, who leads UNICEF’s venture capital arm.
Modality Solutions – Boots on the Ground in Africa
Modality Solutions has extensive hands-on experience managing cold chain logistics hurdles and validating a supply chain in a Zone IV ICH stability zone with its own set of unique challenges not faced by typical supply chains. Primarily, the availability of resources needed to make a shipment as documented in the validation master plan. A refrigerated truck, dry ice, or even a basic polystyrene shipper available one day might not be available the next. Creating standard operating procedures by itself becomes a challenge because there are few things about the supply chain that are standard. Supply chains in these areas are most successful when they are most adaptable. When they have many different options to compensate for when one is not available.
In addition, many areas in these zones have additional hurdles like underdeveloped infrastructure, making it difficult to even get from one location to another. When there are only dirt roads going through a thick brush or arid desert, the supply chain depends on that road being traversable on that day. If it is blocked for whatever reason, there often is no other option. In these areas, there are wet seasons of the year during which the roads are nearly impossible to traverse. In these cases, locals sometimes favour delivering via motorcycle courier instead of a truck because they can drive on the mud roads.
Modality Solutions has experience managing clinical trials for candidate vaccines and treatments for the Ebola virus throughout Western Africa. We are very knowledgeable of the challenges of delivering cold chain therapies in Zone III and IV ICH stability zones. Every member of our team works to maximize clinical trial performance, data integrity, and patient safety. Our cold chain and engineering expertise enabled our in-country, “boots on the ground” team of engineers, project managers, and principals to develop procedures adapted to the specific materials, equipment, and transportation capabilities unique to Western Africa.
Furthermore, the development of these procedures required personnel to travel to relevant facilities and ensure that the requirements of the SOPs were not exceeding the capabilities of equipment and personnel at each site. Our team trained local staff on the SOPs to determine whether the procedures aligned with site capability.
We are the experts in challenging cold chain clinical trial monitoring and logistics and provide operational and technical support to the Ebola vaccination project in Sierra Leone, as well as providing assessments of multiple sites for the NIH vaccine projects in the Caribbean. We understand the challenges faced by health care staff in underdeveloped areas of the world and always maintain a presence throughout the duration of a project, staying close until we know the job is done. Modality Solutions is familiar with the challenges and has the experience and resources to take any existing supply chain logistics plan, validate and integrate it for drone delivery applications.
Operational and Performance Qualification of Drone Deliveries
Completing an operational qualification for an airborne drone presents additional challenges in operational qualification (OQ) and performance qualification (PQ):
- Direct exposure to environmental hazards: Using drone delivery exposes the packaging directly to the outdoor environment for significant periods, which impacts temperature, humidity, shock, and vibration.
- Chain of control and package integrity: Unauthorised access by people or wildlife must be prevented. Easy access to drug product and anti-tampering measures must be validated in extreme hazard conditions.
- Drone equipment and electronics need to be tested and validated for extraordinary circumstances and unusual weather patterns: When navigating undeveloped land, there are a large number of extraordinary circumstances that could occur to interrupt the PQ. For instance, a drone might stand up to gusts of winds but might not survive a mid-air collision with an object or wildlife. High humidity in the environment could be disrupting the electronics, sandstorms that interfere with radio signals, or even the drone parts melting from the solar irradiation. The OQ and the PQs in these circumstances would need a test design for those unique environmental hazards and determining if a drone delivery could complete with a high degree of confidence.
Are you ready? Why go it alone? Predictive drug delivery is on its way
New drug delivery technology requires supply chains to be proactive rather than reactive. Predictive analytics leverage historical and current performance data in order to make predictions on future performance, creating intelligent supply chains capable of swift adaptation and agile decision-making processes, as it is no longer adequate to react to issues after the fact – we must anticipate future performance in order to make intelligent decisions. Cargo drones promise to make systems responsive rather than predictive. With our novel technologies, a proven track record of successful collaborations enabling over 75 new drug approvals, and access to industry influencers, we are prepared to transform your drug delivery operations to a predictive, agile, integrated cold chain.
There are several areas of impact specific to cold chain logistics to consider before integrating drone delivery with your current operations. Updating your Validation Master Plan using these guidelines will give you a head start:
- Implement authentication systems to maintain secure and accurate delivery that includes protocols for replacement or compromised shipments.
- Include protocols that have been tested and validated for the impact of exposure to various weather and environmental hazards: light, wind, humidity, shock, and vibration.
- Create transparency in the supply chain through strategic planning by redefining chain of custody requirements, encouraging compliance with procedures while discouraging theft and improper handling through training and real-time monitoring of product movement.